 |
In today's competitive pharmaceutical industry, strategic licensing agreements and partnerships are key to maintaining a balanced portfolio of products and technologies. Throughout Schering-Plough's history, we have used our broad research expertise and successful therapeutic franchises to attract best-in-class partnerships and alliances that have strengthened our worldwide competitiveness and complemented the work of Schering-Plough Research Institute scientists.
To enhance our research and development capabilities, we aggressively seek to build successful relationships with like-minded companies and institutions. These relationships may take the form of product and technology licenses, alliances, acquisitions or marketing/promotional arrangements. We believe we have the necessary qualities for successful partnering - creativity, commitment, flexibility and experience - supported by a strong technological, business and financial infrastructure. We move quickly and aim for mutually beneficial opportunities.
Schering-Plough's partnership efforts are led by our Global Licensing & Strategic Alliances group, which is comprised of three teams: Search and Evaluation; Engagement and Negotiation; and Alliance Management. This structure reflects the distinct skill sets needed to operate efficiently and quickly in the pharmaceutical licensing marketplace. |
|
CEO Fred Hassan's Remarks from the 3rd Annual Cardiovascular Summit: "Improving Cardiovascular Care: A Noble Mission."